Risk factors for cystoid macular oedema in patients with uveitis

Eye

Volumn 22, Issue 2, 2008, Pages 256-260

  van Kooij, B ^a   Probst, K ^a   Fijnheer, R ^a   Roest, M ^a   de Loos, W ^a   Rothova, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; PREVALENCE; QUESTIONNAIRE; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; UVEITIS;

EID: 39449108855     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702595     Document Type: Article

References (29)

1. Rothova A, Suttorp-van Schulten MS, Treffers WF, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996; 80: 332-336.
2. Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 2004; 88: 1159-1162.
3. Rothova A. Medical treatment of cystoid macular edema. Ocul Immunol Inflamm 2002; 10: 239-246.
4. Jain R, Stevens JD, Bunce CV, Garrett C, Hykin PG. Ischaemic heart disease may predispose to pseudophakic cystoid macular oedema. Eye 2001; 15: 34-38.
5. Jalkh AE, Trempe CL. Macular edema in branch retinal vein occlusion: types and treatment. Ophthalmic Surg 1989; 20: 26-32.
6. Lopes de Faria JM, Jalkh AE, Trempe CL, MCMOel JW. Diabetic macular edema: Risk factors and concomitants. Acta Ophthalmol Scand 1999; 77: 170-175.
7. Wallow IH, Danis RP, Bindley C, Neider M. Cystoid macular degeneration in experimental branch retinal vein occlusion. Ophthalmology 1988; 95: 1371-1379.
8. Gilbert RE, Tsalamandzis C, Allen TJ, Colville D, Jerums G. Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus. J Am Soc Nephrol 1998; 9: 85-89.
9. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE. Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002; 25: 2328-2334.
10. van Kooij B, Fijnheer R, Roest M, Rothova A. Trace microalbuminuria in inflammatory cystoid macular edema. Am J Ophthalmol 2004; 138 1010-1015.
11. Simons PC, Algra A, Bots ML, Grobbee DE, van der GY. Common carotid intima-media thickness and arterial stiffness: Indicators of cardiovascular risk in high-risk patients. The SMART Study (second manifestations of arterial disease). Circulation 1999; 100: 951-957.
12. Lardenoye CW, van Schooneveld MJ, Treffers WF, Rothova A. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol 1998; 82: 1013-1016.
13. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806.
14. Treatment techniques clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987; 94: 761-774.
15. Ibanez HE, Lesher MP, Singerman LJ, Rice TA, Keep GF. Prospective evaluation of the effect of pseudophakic cystoid macula edema on contrast sensitivity. Arch Ophthalmol 1993; 111: 1635-1639.
16. Lardenoye CW, Probst K, DeLint PJ, Rothova A. Photoreceptor function in eyes with macular edema. Invest Ophthalmol Vis Sci 2000; 41: 4048-4053.
17. Freeman G, Matos K, Pavesio CE. Cystoid macular oedema in uveitis: An unsolved problem. Eye 2001; 15: 12-17.
18. Lardenoye CW, Van der LA, de Loos WS, Treffers WF, Rothova A. Peripheral multifocal chorioretinitis: A distinct clinical entity? Ophthalmology 1997; 104: 1820-1826.
19. Rothova A, Berendschot TT, Probst K, van KB, Baarsma GS. Birdshot chorioretinopathy: Long-term manifestations and visual prognosis. Ophthalmology 2004; 111: 954-959.
20. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996; 103: 1846-1853.
21. Weiter JJ, Roh S, Pruett RC. Aging in the retina and choroid. In: Albert DM, Jacobiec FA (eds). Principles and Practice of Ophthalmology. Basic Sciences. WB Saunders Company: Philadelphia, 1994, pp 718-722.
22. Bresnick GH. Diabetic macular edema. A review. Ophthalmology 1986; 93: 989-997.
23. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: Prospective study of 175 cases. Ophthalmology 1996; 103: 551-560.
24. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984; 91: 1464-1474.
25. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998-1003.
26. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Cardiovascular diseases and risk factors in a population-based study in The Netherlands: Agreement between questionnaire information and medical records. Neth J Med 1990; 55: 177-183.
27. Blair NP, Kim SH. Cystoid macular edema after ocular surgery. In: Albert DM, Jacobiec FA (eds). Principles and Practice of Ophthalmology. Basic Sciences. WB Saunders Company: Philadelphia, 1994, pp 903-904.
28. Sebag J, Balazs EA. Pathogenesis of cystoid macular edema: An anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984; 28: 493-498.
29. Bovey EH, Herbort CP. Vitrectomy in the management of uveitis. Ocul Immunol Inflamm 2000; 8: 285-291.